not treatment mandates. These recommendations will provide the backbone for a shared decision-making process between patient and physician regarding perioperative medication management around the time of surgery. The previous Patient Panel provided critical insight into the priorities of patients around the time of THA and TKA and the importance of open discussion and consultation between the perioperative physician, the orthopedic surgeon, and the rheumatologist. One patient representative on